These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice. Montgomery E, Pennington C, Isales CM, Hamrick MW. Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270 [Abstract] [Full Text] [Related]
9. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy. Pinniger GJ, Terrill JR, Assan EB, Grounds MD, Arthur PG. J Physiol; 2017 Dec 01; 595(23):7093-7107. PubMed ID: 28887840 [Abstract] [Full Text] [Related]
10. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy. Gehrig SM, van der Poel C, Hoeflich A, Naim T, Lynch GS, Metzger F. Growth Horm IGF Res; 2012 Apr 01; 22(2):69-75. PubMed ID: 22424862 [Abstract] [Full Text] [Related]
11. The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice. Stupka N, Gregorevic P, Plant DR, Lynch GS. Acta Neuropathol; 2004 Apr 01; 107(4):299-310. PubMed ID: 14727129 [Abstract] [Full Text] [Related]
14. Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for Duchenne muscular dystrophy. Hibaoui Y, Reutenauer-Patte J, Patthey-Vuadens O, Ruegg UT, Dorchies OM. J Pineal Res; 2011 Sep 01; 51(2):163-71. PubMed ID: 21486366 [Abstract] [Full Text] [Related]